First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT) Competitors GBX 1,628.80 +16.80 (+1.04%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors FBT vs. SGE, AVV, AVST, SOPH, PRSM, KAPE, TRST, KNOS, GBG, and LTGShould you be buying First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation stock or one of its competitors? The main competitors of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation include The Sage Group (SGE), AVEVA Group (AVV), Avast (AVST), Sophos Group plc (SOPH.L) (SOPH), Blue Prism Group (PRSM), Kape Technologies (KAPE), Trustpilot Group (TRST), Kainos Group (KNOS), GB Group (GBG), and Learning Technologies Group (LTG). These companies are all part of the "software - application" industry. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation vs. The Sage Group AVEVA Group Avast Sophos Group plc (SOPH.L) Blue Prism Group Kape Technologies Trustpilot Group Kainos Group GB Group Learning Technologies Group First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) and The Sage Group (LON:SGE) are both mid-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, community ranking, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment. Does the media refer more to FBT or SGE? In the previous week, The Sage Group had 1 more articles in the media than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. MarketBeat recorded 1 mentions for The Sage Group and 0 mentions for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's average media sentiment score of 0.00 equaled The Sage Group'saverage media sentiment score. Company Overall Sentiment First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Neutral The Sage Group Neutral Which has preferable earnings and valuation, FBT or SGE? The Sage Group has higher revenue and earnings than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation is trading at a lower price-to-earnings ratio than The Sage Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation£870.31K5,530.07N/A-£1.10-1,480.73The Sage Group£2.25B4.36£267M£0.263,788.46 Do insiders & institutionals have more ownership in FBT or SGE? 67.0% of The Sage Group shares are held by institutional investors. 1.1% of The Sage Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is FBT or SGE more profitable? The Sage Group has a net margin of 11.87% compared to First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's net margin of 0.00%. The Sage Group's return on equity of 22.31% beat First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's return on equity.Company Net Margins Return on Equity Return on Assets First Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/A N/A N/A The Sage Group 11.87%22.31%7.58% Do analysts rate FBT or SGE? The Sage Group has a consensus target price of GBX 1,173, indicating a potential upside of 19.09%. Given The Sage Group's higher probable upside, analysts clearly believe The Sage Group is more favorable than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AThe Sage Group 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Does the MarketBeat Community believe in FBT or SGE? The Sage Group received 452 more outperform votes than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation when rated by MarketBeat users. However, 66.67% of users gave First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation an outperform vote while only 45.06% of users gave The Sage Group an outperform vote. CompanyUnderperformOutperformFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationOutperform Votes7266.67% Underperform Votes3633.33% The Sage GroupOutperform Votes52445.06% Underperform Votes63954.94% SummaryThe Sage Group beats First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation on 12 of the 14 factors compared between the two stocks. Ad InvestorPlaceWhy Buffett, Bezos, & Congress Are Piling Into This One SectorWhy are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market…Click here for the details Get First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation News Delivered to You Automatically Sign up to receive the latest news and ratings for FBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FBT vs. The Competition Export to ExcelMetricFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationSoftware IndustryComputer SectorLON ExchangeMarket Cap£4.81B£2.65B£23.99B£1.58BDividend YieldN/A3.05%2.75%11.08%P/E Ratio-1,480.73815.16253.401,723.54Price / Sales5,530.075,340.803,721.07228,959.04Price / Cash3.5415.6132.0835.69Price / Book857.2614.586.982.87Net IncomeN/A£32.00M£670.43M£144.80M7 Day PerformanceN/A0.84%-0.33%0.11%1 Month Performance2.96%-0.13%0.64%-0.16%1 Year PerformanceN/A21.13%20.35%15.21% First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FBTFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/AGBX 1,628.80+1.0%N/A+21.4%£4.81B£870,310.00-1,480.7320Positive NewsSGEThe Sage Group0.7516 of 5 starsGBX 985+1.6%GBX 1,173+19.1%+0.5%£9.81B£2.25B3,788.4611,326Dividend IncreaseAVVAVEVA GroupN/AN/AN/AN/A£9.72B£1.26B-154.766,250Gap UpAVSTAvastN/AGBX 716.60-0.5%N/A+0.0%£7.49B£940.10M3,115.651,800High Trading VolumeSOPHSophos Group plc (SOPH.L)N/AN/AN/A+0.0%£2.99B£726.90M341.41520PRSMBlue Prism GroupN/AN/AN/AN/A£1.24B£167.30M-23.681,025High Trading VolumeKAPEKape TechnologiesN/AN/AN/A+0.0%£1.22B£623.48M1,900.00850Gap DownTRSTTrustpilot Group0.5992 of 5 starsGBX 252+1.6%GBX 260+3.2%+152.5%£1.05B£191.59M8,400.00820KNOSKainos Group2.2817 of 5 starsGBX 743-0.5%GBX 1,200+61.5%-32.7%£934.99M£382.39M1,905.132,953News CoverageGap DownGBGGB Group0.6062 of 5 starsGBX 343.40+0.9%GBX 356.67+3.9%+43.3%£865.78M£277.32M-1,807.371,183LTGLearning Technologies Group1.4395 of 5 starsGBX 90.60+0.7%GBX 90-0.7%+42.1%£717.54M£528.05M2,265.005,001News CoverageGap Up Related Companies and Tools Related Companies The Sage Group Competitors AVEVA Group Competitors Avast Competitors Sophos Group plc (SOPH.L) Competitors Blue Prism Group Competitors Kape Technologies Competitors Trustpilot Group Competitors Kainos Group Competitors GB Group Competitors Learning Technologies Group Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:FBT) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
